KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $397.1 million.

  • Novavax's Non-Current Deffered Revenue fell 2294.76% to $397.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $397.1 million, marking a year-over-year decrease of 2294.76%. This contributed to the annual value of $446.8 million for FY2024, which is 2818.84% down from last year.
  • Novavax's Non-Current Deffered Revenue amounted to $397.1 million in Q3 2025, which was down 2294.76% from $399.3 million recorded in Q2 2025.
  • Novavax's 5-year Non-Current Deffered Revenue high stood at $1.0 billion for Q3 2022, and its period low was $172.5 million during Q4 2021.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $481.1 million (2024), whereas its average is $518.7 million.
  • In the last 5 years, Novavax's Non-Current Deffered Revenue surged by 24680.13% in 2023 and then plummeted by 5132.86% in 2025.
  • Quarter analysis of 5 years shows Novavax's Non-Current Deffered Revenue stood at $172.5 million in 2021, then increased by 4.01% to $179.4 million in 2022, then soared by 246.8% to $622.2 million in 2023, then decreased by 28.19% to $446.8 million in 2024, then fell by 11.13% to $397.1 million in 2025.
  • Its Non-Current Deffered Revenue was $397.1 million in Q3 2025, compared to $399.3 million in Q2 2025 and $409.6 million in Q1 2025.